Dengue Testing Market Size, Share, Growth, and Industry Analysis, By Type (ELISA-Based Tests, RT-PCR Based Tests, & Dengue IgG/IgM Rapid Test), By Application (Hospitals, Public Health Laboratory, Diagnostic Centers, & Others), Regional Insights, and Forecast To 2032

• 

   Request a Free Sample To Get More Information on this Market

DENGUE TESTING MARKET REPORT OVERVIEW

Global Dengue Testing Market size was anticipated to be worth USD billion in 2023, projected to reach USD billion by 2032 at a 3.5% CAGR during the forecast period.

In addition to other factors, the dengue testing market is growing fast because of its importance as a diagnostic tool, especially in areas where dengue epidemics often occur. Worldwide, with the increasing cases of dengue fever and heightened awareness of the disease, demand for fast and accurate diagnostic tests is rising. Manufacturers are considering upcoming challenging tasks for their new innovative testing products that are able to provide high sensitivity, specificity, and ease of use in accordance with the needs of healthcare providers and patients.

The introduction of stringent regulatory standards and the importance of disease surveillance and control are emerging as major drivers in the dengue test market. The regulatory authorities are increasingly demanding the setting of quality standards to make dengue diagnostic tests more reliable and accurate. Producers of diagnostic kits are investing in research and development to develop regulative approved assays and dengue epidemiological evolution oriented design. These regulatory transformations are shaping the market dynamics and urge the manufacturers to continuously innovate and adapt to serve this niche market segment of dengue accurate and effective testing solutions.

COVID-19 Impact: Market Growth Restrained by Pandemic due to Lockdown Restrictions

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic brought about negative effects on the dengue testing market, like interference in the testing infrastructure, supply chains, and healthcare services. Since efforts are directed towards screening and treatment of COVID-19, the resources and attention have been displaced to the contrary of dengue testing. Likewise, lockdowns and travel bans have lowered the availability of health facilities, causing many dengue diagnosis or treatments to be delayed as well. Indeed, the pandemic economic recession arose with budget restrictions for the healthcare systems as investments in dengue testing and research were reduced. In general, the COVID-19 pandemic has worsened the existing problems of dengue testing, putting an obstacle in the way of controlling and preventing transmission of the disease.

LATEST TRENDS

"Rise of Point-of-Care Testing Solutions to Reshape the Market"

Among trends in the dengue testing market, a significant one is a growing preference for point-of-care testing tools. To ease the stress of fast and precise diagnosis, providers are using portable and uncomplicated medical devices to provide instant results. The detection kits at the point-of-care provide expediency in terms of time, so as to aid patients in their timely management thus relieving the need for centralized laboratories. The move is influenced by the trend of decentralized global healthcare and it allows the healthcare professionals to fastly detect and manage such cases, especially in the situations where resources are limited.

DENGUE TESTING MARKET SEGMENTATION

By Type

Based on type the global market can be categorised into ELISA-Based Tests, RT-PCR Based Tests, & Dengue IgG/IgM Rapid Test.

• ELISA-Based Tests: It involves the detection of dengue virus antigens or antibodies using enzyme-linked immunosorbent assay (ELISA) technology.

• RT-PCR Based Tests: It utilizes reverse transcription-polymerase chain reaction (RT-PCR) to detect viral RNA in patient samples with high accuracy and speed.

• Dengue IgG/IgM Rapid Tests: They are point-of-care assays that detect dengue-specific immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies in patient blood samples.

By Application

Based on application the global market can be categorised into Hospitals, Public Health Laboratory, Diagnostic Centers, & Others.

• Hospitals: They serve as primary points of care for patients presenting with dengue symptoms, where rapid and accurate diagnosis is crucial for timely treatment and management.

• Public Health Laboratories: They play a key role in disease surveillance and outbreak monitoring by conducting large-scale dengue testing on samples collected from communities and populations at risk.

• Diagnostic Centers: They offer specialized testing services to healthcare providers and individuals seeking dengue diagnosis.

• Others: This category encompasses additional settings where dengue testing may occur, such as research institutions, non-governmental organizations (NGOs), and mobile health clinics, reflecting the broad scope of dengue diagnostic applications across various sectors and contexts.

DRIVING FACTORS

"Increasing Global Incidence of Dengue Fever Propels Market Growth"

The main factor powering the dengue testing market growth is the upsurge in incidence of dengue fever around the globe. Due to the malaria virus spread over 100 countries, the global disease burden is about 390 million cases per year. The growing frequency of dengue outbreaks which are mainly concentrated in the tropics and subtropics, makes sihns more necessary for the detection and treatment of dengue cases. Besides the dengue fever which poses serious public health problems, such as severe disease among patients and potential outbreaks, healthcare systems and governments have put more weight to dengue testing as part of deeper disease surveillance for control.

"Growing Emphasis on Early Diagnosis and Treatment to Fuel Market Expansion"

Furthermore, another significant force in the market is for the early diagnosis and treatment to reduce complications of the dengue fever which helps in mitigation of the impact of this disease. Early detection of dengue contributes significantly to prevention of severe complications and to address this problem, rapid and needed intervention is given to the infected persons. There's a growing awareness of healthcare providers about the significance of situations such as rapid and accurate RT-PCR testing assay and rapid decision making test for early diagnosis and for better patient outcome. Similarly, public health campaigns and initiatives geared towards increasing people's knowledge about fever of dengue and the significance of early testing and treatment are other drivers of demande for the dengue diagnostic tests.

RESTRAINING FACTORS

"Limited Access to Healthcare Infrastructure to Impede the Market Expansion"

The primary restraining force of the dengue testing market, especially in some low and middle-income countries where dengue fever is prevalent, is the limited access to healthcare infrastructure. The inexistence of sufficiently equipped healthcare facilities or shortage of trained personnel in rural or remote areas makes it difficult or impossible to get the dengue diagnosis done within a reasonable time. Besides that, low finances or the cost paid by the patients themselves may discourage the people from looking for dengue testing, which eventually leads the dengue fever toward underdiagnosis and underreporting. While removing these obstacles to healthcare provision is critical in improving dengue detection rate and responding expediently to dengue outbreaks.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market

DENGUE TESTING MARKET REGIONAL INSIGHTS

"Asia Pacific Leads the Market with Large Pouplation Base"

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

Asia-Pacific is the region with the greatest dominance in the dengue testing market share because of the high burden of dengue fever in the region and a large population vulnerable to infection. Countries in the Asia-Pacific region like India, Indonesia, Thailand, and the Philippines have frequent dengue and other mosquito-borne disease outbreaks caused by factors such as urbanization, population concentration, and tropical climate favouring mosquito breeding. The necessity of dengue virus detection in these countries in relation to disease surveillance, outbreak management, and patient care cannot be overemphasized. This array of factors cumulatively makes Asia-Pacific the leading avenue for dengue testing as an industry.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Innovation and Market Expansion"

A number of market players, which are influential in the differential dengue testing market landscape, denote some of the big industry players. The company offers a wide variety of test kits that include ELISA based assays, RT-PCR kits as well as rapid diagnostic tests. These test kits can be used both to tackle the health concerns of the vendors and also the patients. The top dengue industry companies do extensive research and development to allow dengue testing devices to be as sensitive, specific, better and user-friendly as possible and that models the future direction of the entire industry. Indeed, with their key players being discovered, these industry players play a central role towards the scale up of dengue tests and the improvement in patient health outcomes on a worldwide basis.

LIST OF TOP DENGUE TESTING MARKET COMPANIES

• Abnova (Taiwan)
• Roche Molecular Systems (U.S.)
• Abbott Laboratories (U.S.)
• InBios International (U.S.)
• NovaTec Immundiagnostica (U.S.)
• Sub.PerkinElmer (Germany)
• Quest Diagnostics (U.S.)

INDUSTRIAL DEVELOPMENT

February 2020: Rapid Multiplex Dengue Tests has been one of the several latest innovations in the market. These tests can simultaneously detect the presence of multiple dengue virus serotypes (DENV 1-4) and differentiate them from other circulating viruses. This provides a more precise diagnosis and helps determine the appropriate course of treatment.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.